ArsenalBio

South San Francisco, CA · Founded 2018 · Privately Held (backing)

Operator of a programmable cell therapy company intended to discover, develop, and commercialize curative immune cell therapies. ArsenalBio is based in South San Francisco, CA and was founded in 2018. Its last known valuation is $1.9 billion. It has raised $631 million.

Last price · $/share
—
Implied valuation
$1.9B
Total raised
$630.8M
Last round
—
What is ArsenalBio worth?
$1.9Blast known valuation
Free account
More of ArsenalBio with a free account
  • ·The complete investor list: 24 names
  • ·Watch ArsenalBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

ArsenalBio funding history

No rounds on record

No funding rounds for ArsenalBio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

ArsenalBio valuation

ArsenalBio's last known valuation is $1.9 billion. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How ArsenalBio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For ArsenalBio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about ArsenalBio

What is ArsenalBio worth?
ArsenalBio's last known valuation is $1.9B.
How much has ArsenalBio raised?
ArsenalBio has raised $630.8M in total funding across its recorded rounds.